Michael Barbella, Managing Editor07.11.23
Henry Schein Inc. has acquired Regional Health Care Group Pty. Ltd. (RHCG), a medical products distribution company serving public and private sector customers in Australia and New Zealand. Financial terms were not disclosed.
Since 1998, Henry Schein has served the Australian and New Zealand dental market, providing a wide range of dental products, equipment, and services to dental professionals. The addition of RHCG expands Henry Schein’s offering to medical practitioners in the region.
“We are pleased to welcome the Regional Health Care Group to Henry Schein,” Henry Schein Board Chairman and CEO Stanley M. Bergman said. “Together, we will advance our goal of helping health care professionals operate more efficient practices by providing new solutions and technologies for the ultimate benefit of patients.”
Henry Schein acquired RHCG, which reported $42 million in sales for the 12 months ended June 30, 2022, from Maurie and Bernard Stang. The Stangs wholly owned the company and retain a minority interest in Henry Schein’s ANZ dental business. Henry Schein expects the transaction to be neutral to 2023 diluted earnings per share when excluding amortization expenses and accretive thereafter.
Headquartered in Sydney, Australia, with an office in Auckland, New Zealand, RHCG offers a range of consumables, equipment, and pharmaceuticals—including many on an exclusive or semi-exclusive basis—primarily to public- and private-sector customers. The day-to-day operations of RHCG are led by General Manager Stephen Doorey, who will continue to manage the business under the highly regarded Regional Health Care Group brand. Doorey will report to Mike Covey, vice president and managing director of Henry Schein’s business in Australia and New Zealand.
“We are very pleased to integrate RHCG with Henry Schein, a company that shares our commitment to excellent service and provides customers with the solutions they need to deliver quality care to their patients,” Maurie Stang stated. “It’s extremely gratifying to see the exciting opportunities to accelerate our growth.”
Henry Schein Inc. is a solutions company for healthcare professionals powered by a network of people and technology. With more than 22,000 Team Schein members worldwide, the company's network of trusted advisors provides more than 1 million customers globally with over 300 valued solutions that help improve operational success and clinical outcomes. Its business, clinical, technology, and supply chain solutions help office-based dental and medical practitioners work more efficiently so they can provide quality care more effectively. These solutions also support dental laboratories, government and institutional health care clinics, as well as other alternate care sites. Henry Schein operates through a centralized and automated distribution network, with a selection of more than 300,000 branded products and Henry Schein private-brand products in stock.
Since 1998, Henry Schein has served the Australian and New Zealand dental market, providing a wide range of dental products, equipment, and services to dental professionals. The addition of RHCG expands Henry Schein’s offering to medical practitioners in the region.
“We are pleased to welcome the Regional Health Care Group to Henry Schein,” Henry Schein Board Chairman and CEO Stanley M. Bergman said. “Together, we will advance our goal of helping health care professionals operate more efficient practices by providing new solutions and technologies for the ultimate benefit of patients.”
Henry Schein acquired RHCG, which reported $42 million in sales for the 12 months ended June 30, 2022, from Maurie and Bernard Stang. The Stangs wholly owned the company and retain a minority interest in Henry Schein’s ANZ dental business. Henry Schein expects the transaction to be neutral to 2023 diluted earnings per share when excluding amortization expenses and accretive thereafter.
Headquartered in Sydney, Australia, with an office in Auckland, New Zealand, RHCG offers a range of consumables, equipment, and pharmaceuticals—including many on an exclusive or semi-exclusive basis—primarily to public- and private-sector customers. The day-to-day operations of RHCG are led by General Manager Stephen Doorey, who will continue to manage the business under the highly regarded Regional Health Care Group brand. Doorey will report to Mike Covey, vice president and managing director of Henry Schein’s business in Australia and New Zealand.
“We are very pleased to integrate RHCG with Henry Schein, a company that shares our commitment to excellent service and provides customers with the solutions they need to deliver quality care to their patients,” Maurie Stang stated. “It’s extremely gratifying to see the exciting opportunities to accelerate our growth.”
Henry Schein Inc. is a solutions company for healthcare professionals powered by a network of people and technology. With more than 22,000 Team Schein members worldwide, the company's network of trusted advisors provides more than 1 million customers globally with over 300 valued solutions that help improve operational success and clinical outcomes. Its business, clinical, technology, and supply chain solutions help office-based dental and medical practitioners work more efficiently so they can provide quality care more effectively. These solutions also support dental laboratories, government and institutional health care clinics, as well as other alternate care sites. Henry Schein operates through a centralized and automated distribution network, with a selection of more than 300,000 branded products and Henry Schein private-brand products in stock.
